AUSTIN, Texas, Dec. 5, 2016 /PRNewswire/ -- Luminex
Corporation (NASDAQ: LMNX) today announced that the company was
awarded the prestigious R&D 100 Award for its ARIES® Systems at
the 54th Annual R&D 100 Awards ceremony in November. The
R&D 100 Awards, presented by R&D Magazine, is an
international competition that honors the 100 best technologies of
the year. The award recognizes technologically significant products
across a wide range of industries, including telecommunications,
optics, high-energy physics, materials science, chemistry, and
biotechnology, and provides a mark of excellence recognized by
industry, government, and consumers.
"We developed the ARIES® family of systems based on extensive
input from customers, and are honored to win this award on their
behalf," said Homi Shamir, President
and Chief Executive Officer of Luminex. "ARIES® answers many of the
previously unmet needs of our clinical laboratory customers while
delivering accurate and timely data to improve patient care. In the
year that the systems have been on the market, we have been very
encouraged by the response from the laboratory community as well as
the various international regulatory bodies that have issued
approvals or marketing clearance for our ARIES® systems and
assays."
About the ARIES Systems
ARIES® Systems are sample to
answer molecular diagnostic systems designed to increase laboratory
efficiency, ensure result accuracy, and fit seamlessly into today's
lean laboratory environment. ARIES® uses internal barcode scanning
and other advanced features to minimize operator errors.
Independent modules support from one to six cassettes, allowing for
both STAT and Batch testing of IVD assays and laboratory developed
tests (LDTs) with MultiCode® Reagents when using a universal assay
protocol. An integrated touchscreen PC eliminates the need for a
separate computer, standalone keyboard, and mouse, maximizing
valuable bench space.
To learn more or request a demo, visit:
www.luminexcorp.com/ARIES
About Luminex Corporation
At Luminex, our mission is
to empower labs to obtain reliable, timely, and actionable answers,
ultimately advancing health. We offer a wide range of
solutions applicable in diverse markets including clinical
diagnostics, pharmaceutical drug discovery, biomedical research,
genomic and proteomic research, biodefense research, and food
safety. We accelerate reliable answers while simplifying complexity
and deliver certainty with a seamless experience. To learn more
about Luminex, please visit us at www.luminexcorp.com.
Contacts
|
|
Luminex Investor
Contact
|
Luminex Media
Contact
|
Harriss
Currie
|
Christine
Valle
|
Sr. Vice President of
Finance and CFO
|
Sr. Manager, Global
Marketing
|
512.219.8020
|
512.219.8020
|
hcurrie@luminexcorp.com
|
cvalle@luminexcorp.com
|
Photo -
http://photos.prnewswire.com/prnh/20161202/445232
Logo -
http://photos.prnewswire.com/prnh/20150201/172702LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/luminex-wins-rd-100-award-for-aries-systems-300372418.html
SOURCE Luminex Corporation